Passer au contenu

/ École de santé publique

Je donne

Rechercher

Isabelle BOUCOIRAN

Isabelle Boucoiran

Vcard

Professeure agrégée de clinique

Faculté de médecine - Département d'obstétrique-gynécologie

Professeure agrégée de clinique

École de santé publique - Département de médecine sociale et préventive

Courriels

isabelle.boucoiran.med@ssss.gouv.qc.ca (Travail)

Travail 1 : 514 345-4931 #5830

Télécopieur : 514 345-4648

Affiliations

  • Membre – Centre de recherche du CHU Sainte-Justine
  • Membre – SIDA/MI — Réseau sida et maladies infectieuses

Expertises

Responsabilities and outreach Expand all Collapse all

Titres : corporations et organismes professionnels
Activités au sein d’organismes ou d’entités de l’institution
Activités clinique et professionnelle
Participation à des jurys (hors de l’institution)
Autres activités et contributions

Student supervision Expand all Collapse all

Association entre la thérapie antirétrovirale et les biomarqueurs de la fonction placentaire pendant la grossesse Thèses et mémoires dirigés / 2019 - 2019
Graduate : Djeha, Améyo Xoxoabu
Cycle : Master's
Grade : M. Sc.
Thèses et mémoires dirigés
Stages et autres supervisions
Postdoctorants

Research projects Expand all Collapse all

CMV Dynamics and Transmission in Pregnancy: Comparison Between Women Living with and without HIV Projet de recherche au Canada / 2021 - 2026

Lead researcher : Isabelle Boucoiran
Co-researchers : Soren Gantt , Hugo Soudeyns , Fatima Kakkar , Abdoulaye Banire Diallo , Helene Cote , Deborah Money , Laura Sauvé , Chelsea Elwood
Funding sources: IRSC/Instituts de recherche en santé du Canada
Grant programs: PVXXXXXX-(PJT) Subvention Projet

Human Cytomegalovirus as a Driver of Adverse Health Outcomes among Children Exposed to HIV in Utero Projet de recherche au Canada / 2020 - 2025

Lead researcher : Fatima Kakkar
Co-researchers : Hugo Soudeyns , Christian Renaud , Isabelle Boucoiran , Stanley Read , Jason Brophy , Sean Ari Bitnun , Soren Gantt , Michael Hawkes
Funding sources: IRSC/Instituts de recherche en santé du Canada
Grant programs: PVXXXXXX-(PJT) Subvention Projet

The Bhagirath Singh Early Career Prize in Infection and Immunity Projet de recherche au Canada / 2021 - 2023

Lead researcher : Isabelle Boucoiran
Funding sources: IRSC/Instituts de recherche en santé du Canada
Grant programs: PVXXXXXX-Prix

Prévenir les complications périnatales secondaires aux infections par le CMV et le VIH Projet de recherche au Canada / 2020 - 2023

Lead researcher : Isabelle Boucoiran
Funding sources: FRQS/Fonds de recherche du Québec - Santé (FRSQ)
Grant programs: PVXXXXXX-Bourse de chercheur-boursier clinicien : Junior 2

Placental mitochrondrial dysfunction and preterm birth Projet de recherche au Canada / 2019 - 2023

Lead researcher : Helene Cote
Co-researchers : Isabelle Boucoiran
Funding sources: IRSC/Instituts de recherche en santé du Canada
Grant programs: PVXXXXXX-(PJT) Subvention Projet

Non primary cytomegalovirus infections in pregnancy Projet de recherche au Canada / 2017 - 2022

Lead researcher : Isabelle Boucoiran
Co-researchers : Christian Renaud , Jean-Claude Forest , Yves Giguère , Lise Goulet
Funding sources: IRSC/Instituts de recherche en santé du Canada
Grant programs: PVXX5647-(MOP) Subvention de fonctionnement incluant les subventions de fonctionnement programmatiques (général)

Montreal Emerging Research Team in Maternal Fetal Medicine (MERe) Projet de recherche au Canada / 2016 - 2022

Lead researcher : Isabelle Boucoiran
Funding sources: IRSC/Instituts de recherche en santé du Canada
Grant programs: PVXXXXXX-Subvention d'équipe

SIDA-MI//Non primary cytomegalovirus infections in pregnancy. Projet de recherche au Canada / 2020 - 2021

Funding sources: FRQS/Fonds de recherche du Québec - Santé (FRSQ)
Grant programs: PVXXXXXX-Réseaux thématiques de recherche

Uninfected but not unaffected? Health outcomes among HIV-Exposed Uninfected (HEU) Children Projet de recherche au Canada / 2018 - 2019

Lead researcher : Fatima Kakkar
Co-researchers : Hugo Soudeyns , Isabelle Boucoiran , Joel Singer , Joseph Puyat
Funding sources: IRSC/Instituts de recherche en santé du Canada
Grant programs: PVXXXXXX-(PJT) Subvention Projet

La prise en charge des femmes enceintes infectées par le VIH et la prévention de la transmission périnatale du VIH au Québec. Projet de recherche au Canada / 2017 - 2019

Lead researcher : Fatima Kakkar
Co-researchers : Isabelle Boucoiran
Funding sources: MSSS/Ministère de la Santé et des Services sociaux
Grant programs:

Issues périnatales chez les femmes vivants avec le VIH Projet de recherche au Canada / 2015 - 2019

Lead researcher : Isabelle Boucoiran
Funding sources: FRQS/Fonds de recherche du Québec - Santé (FRSQ)
Grant programs: PVXXXXXX-Bourse de chercheur-boursier clinicien : Junior 1

Réseau SIDA/MI - Impact of antiretroviral therapy use in pregnancy on placental functions. Projet de recherche au Canada / 2016 - 2018

Lead researcher : Isabelle Boucoiran
Funding sources: FRQS/Fonds de recherche du Québec - Santé (FRSQ)
Grant programs: PVXXXXXX-Réseaux thématiques de recherche

Issues périnatales chez les femmes vivants avec le VIH Projet de recherche au Canada / 2015 - 2018

Lead researcher : Isabelle Boucoiran
Funding sources: FRQS/Fonds de recherche du Québec - Santé (FRSQ)
Grant programs: PVXXXXXX-Établissement de jeunes chercheurs Juniors 1

Fonds de démarrage Projet de recherche au Canada / 2015 - 2018

Lead researcher : Isabelle Boucoiran
Funding sources: Fondation de l'Hôpital Ste-Justine
Grant programs:

Evaluation of Cabergline for Lactation Suppression in Women Living with HIV. Projet de recherche au Canada / 2016 - 2017

Lead researcher : Isabelle Boucoiran
Funding sources: CANFAR/Fondation canadienne pour la recherche sur le SIDA (CANFAR)
Grant programs:

Déploiement et transfert de TAVIE en santé pour soutenir les personnes vivant avec le VIH à relever leurs défis de santé : alliance entre les milieux de soins et communautaires. Projet de recherche au Canada / 2016 - 2017

Lead researcher : José Côté
Co-researchers : Sylvie Cossette , Maria-Pilar Ramírez García , Valérie Martel-Laferrière , Isabelle Boucoiran , Alexandra De Pokomandy
Funding sources: IRSC/Instituts de recherche en santé du Canada
Grant programs: PVXXXXXX-Subventions pour réunion, planification et dissémination

Le transfert clinique de TAVIE-Femme: une intervention virtuelle destinée aux femmes vivant avec le VIH pour les soutenir dans la prise des antirétroviraux Projet de recherche au Canada / 2016 - 2017

Lead researcher : José Côté
Co-researchers : Isabelle Boucoiran , Alexandra De Pokomandy
Funding sources: IRSC/Instituts de recherche en santé du Canada
Grant programs: PVXXXXXX-Subventions pour réunion, planification et dissémination

Publications Expand all Collapse all

Peer-reviewed publications - published or in press

  1. Boucoiran I, Van Schalkwyk J, Alimenti A, Maan E, Albert A, Wagner E, Chaworth-Muster T, Forbes J, Pick N, Money D, Oak Tree Clinic Research Group. HIV Viral Rebound Near Delivery In Previously suppressed, Combined Antiretroviral Therapy Treated Pregnant Women. Obstetrics & Gynecology [accepted]
  2. Cote J, Rouleau G, Thouvenot VI, Boucoiran I, De Pokomandy A. TAVIE-Woman™: A web-based virtual nursing intervention to meet the specific needs of women living with HIV. Journal of the International Society for Telemedicine and eHealth 5:e3.
  3. Desjardins M, Labbé AC, Boucoiran I, Paquet C, Laferrière C, Gosselin-Brisson A, Martel-Laferrière . Healthcare Providers' Attitude Towards Influenza Vaccination During Pregnancy: A Quebec Survey. Journal of the Association of Medical Microbiology and Infectious Disease Canada. [accepted]
  4. Vaujois L, Boucoiran I, Brassard M, Houde C, Fouron JC, Raboisson MJ. Relashionship between pulmonary flow and physiological shunts in fetuses with transposition of the great arteries at risk for neonatal hypoxia. Cardiol Young. 2017 Apr 5:1-9. [epub ahead of print]
  5. Gantt S, Leister E, Jacobson DL, Boucoiran I, Huang ML, Jerome KR, Jourdain G, Ngo-Giang-Huong N, Burchett S, Frenkel L. Risk of congenital cytomegalovirus infection among HIV-exposed uninfected infants is not decreased by maternal nelfinavir use during pregnancy. J Med Virol 2016 Jun;88(6):1051-8.
  6. Martillotti G, Boucoiran I, Dubé E, Damphousse A, Grignon A, Moussa A, Bouchard S, Morin L. Predicting gastroschisis perinatal outcome from antenatal characteristics. Fetal Diagnosis and Therapy 2016;39(4):279-86.
  7. Jordan A, El Haloui O, Breaud J, Chevalier D, Antomachi J, Bongain A, Boucoiran I, Delotte J. Training of residents in obstetrics and gynecology: an educational program including formal lectures and practical sessions using simulators. J. Gynecol Obstet Fertil. 2015 Jul-Aug;43(7-8):560-7.
  8. Boucoiran I, Tulloch K, Kakkar F, Pick N, Money D, Boucher M. Third trimester Raltegravir initiation: impact on maternal HIV viral load and obstetrical outcome. CJIDMM 2015 May-Jun;26(3):145-50.
  9. Kakkar F, Boucoiran I, Lamarre V, Boucher M, Lapointe N. Boosted protease inhibitor-based regimens increase the risk of preterm birth. Journal Int AIDS Soc 2015 Jun 5;18:19933.
  10. El Haloui O, Delotte J, Gillard C, Boukaïdi S, Bongain A, Boucoiran I. [Instrumental extractions using Thierry's spatulas: evaluation of the learning curve]. Gynecol Obstet Fertil. 2015 Jan;43(1):3-7.
  11. Maisonneuve E, Delvin E, Ouellet A, Morin L, Dubé J, Boucoiran I, Moutquin JM, Fouron JC, Klam S, Levy E, Leduc L. Oxidative conditions prevail in severe IUGR with vascular disease and Doppler anomalies. J Matern Fetal Neonatal Med. 2015 Aug;28(12):1471-5.
  12. Fuchs F, Boucoiran I, Picard A, Dube J, Wavrant S, Bujold E, Audibert F. Impact of amniotic fluid "sludge" on the risk of preterm delivery. J Matern Fetal Neonatal Med. 2015 Jul;28(10):1176-80.
  13. Money D, Boucoiran I, Wagner E, Dobson S, Cole L, Krajden M, Yoshida EM, and the HCV Perinatal Study group. Obstetrical and neonatal outcomes among women infected with Hepatitis C and their infants in Canada. J Obstet Gynaecol Can. 2014 Sep;36(9):785-94.
  14. Vieille P, De Tayrac R, Hudry D, Boucoiran I, Wafo E, Badiou W. [Impact of a training workshop on interns and senior registrar skill in diagnosis and repair of anal sphincter and rectal mucosae obstetrical injuries]. Progrès en Urologie 2014 Mar;24(4):240-6.
  15. Thissier-Levy S, Boucoiran I, Wu Y, Wei Sq, Luo Zc, Nuyt Am, Julien P, Fraser W, Audibert F. Endostatin levels and the risk of subsequent preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2013 Oct;170(2):396-400.
  16. Boucoiran I, Djemli A, Taillefer C, Rypens F, Delvin E, Audibert F. First trimester prediction of birth weight. American J Perinatol. 2013 Sep;30(8):665-72
  17. Boucoiran I, Suarthana E, Rey E, Fraser W, Delvin E, Audibert F. Repeated measures of PlGF, PP13 and ADAM12s at first and second trimester for preeclampsia screening. American J Perinatol. 2013 Sep;30(8):681-8.
  18. Boucoiran I, S. Thissier-Levy S, Wu Y, Wei SQ, Luo ZC, Delvin E, Fraser W, Audibert F. Risk for preeclampsia and intrauterine growth restriction: effective value of PlGF, Sflt-1 and Inhibin A in singleton and multiple pregnancies. American J Perinatol. 2013 Aug;30(7):607-12.
  19. Kadhel P, Monnier P, Boucoiran I, Chaillet N, Fraser W. Impact of Persistent Organochlorinated Pollutants on Women’s Fertility: a Systematic Review as seen through In Vitro Fertilization Studies. Reprod Sci. 2012 Dec;19(12)1246-59.
  20. Masse V, Ferrari P, Boucoiran I, Delotte J, Isnard V, Bongain A. Normal serum concentrations of Anti Müllerian Hormone in a population of fertile women in their first trimester of pregnancy. Human Reprod. 2011 Dec;26(12):3431-6.
  21. Audibert F, Boucoiran I, An N, Aleksandrov N, Delvin E, Bujold E, Rey E. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. Am J Obstet Gynecol. 2010 Oct;203(4):383.e1-8.4.
  22. Boucoiran I, Valerio L, Bafghi A, Delotte J, Bongain A. Spatula-assisted deliveries: a large cohort of 1065 cases. Eur J Obstet Gynecol Reprod Biol. 2010 Jul;151(1):46-51.

Peer-reviewed publications – under review

Boucoiran I, Mayer BT, Krantz E, Boppana S, Wald A, Corey L, Casper C, Schiffer JT, Gantt S. Recurrent maternal CMV infection following primary infection in infants.

Berard A, Sheehy O, Zhao J, Abrahamowicz M, Boucoiran I, Boucher M, Loutfy M, Bernatsky S. Antiretroviral therapy use during pregnancy and the risk of major congenital malformations. AIDS.

Editorials / letters to editors

  1. Moullec G, Boucoiran I. [G. Moullec and I. Boucoiran in reply to the article by G. Filhol et al. International recommendations on physical exercise for pregnant women]. Gynecol Obstet Fertil. 2015 Jan;43(1):91-2.
  2. Boucoiran I. [The resident: How to be a student and a teacher at the same time?]. Gynecol Obstet Fertil. 2011 Oct;39(10):594.
  3. Boucoiran I. [Can we learn humanism in the management of patients?]. Gynecol Obstet Fertil. 2011 Jun;39(6):398.
  4. Boucoiran I. [Residents in gynecology-obstetrics: are we concerned by burn out?]. Gynecol Obstet Fertil. 2011 Feb;39(2):116.
  5. Boucoiran I. [A place for clinical research training during residentship]. Gynecol Obstet Fertil. 2010 Jun;38(6):428.
  6. Boucoiran I, Bongain A. [How I do... to write an abstract]. Gynecol Obstet Fertil. 2010 May;38(5):366.

Book chapters

  1. Boucoiran I, C. Paquet C. Infections in pregnancy. Mc Master ebook. [in progress].
  2.  Boucoiran I, Desilets, V, Audibert, F. Care Path in Neonates. Management of fetus with non-immune hydrops, McGraw Hill Education, [Epub ahead of print].
  3. Boucoiran I, Ferreira E, Gagné C. Soins pré-conceptionnels et soins post partum. Grossesse et allaitement : guide thérapeutique, 2nd edition, CHU Sainte-Justine Edition, 2013.
  4. Boucoiran I, Maisonneuve E, Wavrant S. Complications obstétricales : membranes rompues, tocolyse, prévention de la prématurité. Grossesse et allaitement : guide thérapeutique, 2nd edition, CHU Sainte-Justine Edition, 2013.

Abstracts (published)

  1. Boucoiran I, T. Lee T, Tulloch K, Sauve L, L. Samson L, J. Brophy J, Boucher M, Money D. The use of antiretroviral agents during pregnancy in Canada and compliance with North American guidelines.  Reviews in Antiviral Therapy & Infectious Diseases. 2016;01:16.
  2. Thériault K, Boucoiran I, Jarcevic R, Dal Soglio D, Wavrant S. Added value of placental examination in the investigation of stillbirth. Am J Obstet Gynecol. 2015 Dec (presented in February 2016)
  3. Kakkar F, Boucoiran I, Lee T, Sauve L, Singer J, Samson L, Money D and members of the Canadian Pediatric HIV Surveillance Program (CPHSP). High Rates of Preterm Birth and Small for Gestational Age in a Cohort of HIV Infected Women in Canada: Role of Ritonavir Boosted Regimens? Open Forum Infectious Diseases (Fall 2014) 1 (suppl 1): S430-S431.
  4. Picard A, Boucoiran I, Wavrant S, Dube J, Bujold E, Audibert F. Intra-amniotic sludge observed at cervical ultrasound and the risk of preterm delivery. Ultrasound in Obstetrics and Gynecology. 2013 Oct; 42 (S1): 77 (presented in September 2013)
  5. Boucoiran I, Wavrant S, Rypens F. Prenatal diagnosis of hydromyelia: a case report. Ultrasound in Obstetrics and Gynecology. 2012 Oct; 40 (S1):237 (presented in September 2012)
  6. Martillotti G, Boucoiran I, Dubé E, Damphousse A, Grignon A, Moussa A, Bouchard S, Morin L. Predicting gastroschisis perinatal outcome from antenatal characteristics. Ultrasound in Obstetrics and Gynecology. 2012 Oct; 40 (S1):292 (presented in September 2012)
  7. Martillotti G, Boucoiran I, Morin L, Fouron JC. Is the circulatory dynamics of fetuses with gastroschisis different from normal? Ultrasound in Obstetrics and Gynecology. 2012 Oct; 40 (S1):135 (presented in September 2012)
  8. Clermont ME, Morin L, Boucoiran I, Dubé J, Codsi E, Audibert F, Wavrant S. Validity of first trimester 3D foetal anatomy assessment. Ultrasound in Obstetrics and Gynecology. 2012 Oct; 40 (S1):274 (presented in September 2012)
  9. Maisonneuve E, Delvin E, Levy E, Ouellet A, Grenier E, Morin L, Dubé J, Boucoiran I, Bouity-Voubou M, Moutquin JM, Fouron JC, Klam S, Leduc L. Severity of foetal growth restriction from placental insufficiency is associated with a oxidative stress markers response in umbilical cord blood. Ultrasound in Obstetrics and Gynecology 2012 Oct; 40 (S1):48 (presented in September 2012)
  10. Boucoiran I, Delvin E, Rypens F, Rey E, Audibert F. Repeated measures of PlGF, PP13 and ADAM12 at first and second trimester for preeclampsia screening. Am J Obstet Gynecol. 2011 Dec; 206(1),S337 (presented in February 2012)
  11. Boucoiran I, S. Thissier-Levy S, Wu Y, Wei SQ, Luo ZC, Delvin E, Fraser W, Audibert F. Risk for preeclampsia and intrauterine growth restriction: effective value of PlGF, Sflt-1 and Inhibin A in singleton and multiple pregnancie. Am J Obstet Gynecol. 2011 Dec; 206(1),S336-337 (presented in February 2012)
  12. Thissier-Levy S, Boucoiran I, Wu Y, Wei SQ, Luo ZC, Nuyt AM, Fraser W, Audibert F. Endostatin: a new biomarker of preeclampsia ? Am J Obstet Gynecol. 2011 Dec; 206(1),S334 (presented in February 2012)
  13. Boucoiran I, Taillefer C, Wavrant S, Morin L, Dubé J, Hudon L, Audibert F. First trimester prediction of birth weight. Ultrasound in Obstetrics and Gynecology. 2011 Oct; 38 (S1):128 (presented in September 2011).
  14. Wavrant S, Boucoiran I, Maisonneuve E, Audibert F, Rypens R. Prenatal diagnosis of schizencephaly: two cases. Ultrasound in Obstetrics and Gynecology. 2011 Oct; 38 (S1):203-204. (presented in September 2011).
  15. Wavrant S, Boucoiran I, Tordjman L, Gauthier R, Bortoluzzi P, Rypens F, Morin L, Audibert F. Severe fetal head moulding without labor. Ultrasound in Obstetrics and Gynecology. 2011 Oct; 38 (S1):222 (presented in September 2011).
  16. Wavrant S, Boucoiran I, Brunet S, Audibert F, Morin L. Resolving access limitation to first trimester Down syndrome screening: is 3D nuchal translucency measurement combined with biochemical markers valid? Ultrasound in Obstetrics and Gynecology. 2010 Oct; 36 (S1):181-182 (presented in September 2010).
  17. Audibert F, Boucoiran I, Brunet S, Rypens F, Grignon A, Rey E. Screening for preeclampsia using first and second trimester uterine artery Doppler and maternal characteristics in nulliparous women. Am J Obstet Gynecol. 2009 Dec;201(6), S115 (presented in February 2010)
  18. Boucoiran I, Rey E, Delvin E, An N, Audibert F. Screening for preeclampsia using first trimester serum markers in nulliparous women. Am J Obstet Gynecol. 2009 Dec;201(6), S268 (presented in February 2010)

Nationa Clinical guidelines

  1. van Schalkwyk J, Yudin MH, SOGC Infectious Disease Committee, Yudin MH, Allen V, Bouchard C, Boucher M, Boucoiran I, Caddy S, Castillo E, Kennedy VL, Money DM, Murphy K, Ogilvie G, Paquet C, van Schalkwy JK; Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis. J Obstet Gynaecol Can. 2015 Mar;37(3):266-76.
  2. Money D; Infectious Disease Committee Members, Yudin MH, Allen V, Bouchard C, Boucher M, Boucoiran I, Caddy S, Castillo E, Kennedy VL, Money D, Murphy K, Ogilvie G, Paquet C, van Schalkwyk J. SOGC committee opinion on the management of a pregnant woman exposed to or infected with Ebola virus disease in Canada. J Obstet Gynaecol Can. 2015 Feb;37(2):182-91
  3. Money, D, Tulloch K, Boucoiran I, Alimenti A, Sauve L, Pick N, Caddy S, Van Schalkwyk J. Recommandations de la SOGC: Guidelines for the care of HIV positive pregnant women and interventions to reduce perinatal transmission. J Obstet Gynaecol Can. 2014 Aug;36(8):721-51.
  4. Crane J, Mundle W, Boucoiran I. SOGC Guidelines: Parvovirus B19 infection in pregnancy. J Obstet Gynaecol Can. 2014 Dec;36(12):1107-16.

Communications Expand all Collapse all

Guest speaker Presentations

  1. Zika versus CMV : une perspective québécoise, Formation Médicale Continue de la SOGC, Mont tremblant (Qc), October 2017.
  2. Le virus Zika : que doivent savoir les obstétriciens-gynécologues ? Congrès de l’AOGQ, Montreal (Qc), May 2017.
  3. Gynecologica infections. Canadian Obstetrics and Gynecology Review Program, Toronto (Ont), Feb 2017
  4. Le virus Zika. Formation Médicale Continue de la SOGC, Montreal (Qc), October 2016.
  5. Accouchements prématurés chez les femmes vivant avec le VIH : causes et lien avec la thérapie antirétrovirale. Colloque Femmes et VIH : Recherche et pratiques d'intervention. 84th meeting of the “Association Francophone pour le Savoir”, Montreal (Qc), May 2016.
  6. HIV et grossesse: cas pratiques. Comité des pharmaciens experts en VIH. Programme National de Mentorat sur le VIH-Sida, Montreal (Qc), January 2016.
  7. Infections maternelles pendant la grossesse et repercussions foetales. Formation Médicale Continue de la SOGC, Montebello (Qc), October 2015.
  8. HIV et grossesse: cas pratiques. 10e Week-end de formations des médecins oeuvrant en VIH, Orford (Qc), September 2015.
  9. Management of HIV+ pregnancies. Chronic Viral Illness Service – McGill University Health Centre, Montreal (Qc), September 2015.
  10. Cytomegalovirus et grossesse : quand y penser, nouvelles perspectives. Journées annuelles du department de Gynécologie-Obstétrique de l’Université de Montréal, Mont-Tremblant (Canada), February 2015.
  11. Genital Herpes in the obstetrical population. Annual meeting of the "Association des Obstétriciens Gynécologues du Québec". Mont-Tremblant (Canada), May 2014.
  12. Infectious diseases and pregnancy. Mother-Child Network. Montreal (Canada), Dec 2012.

Oral Presentations

  1. Roy M, Thibaudeau R, Tulloch K, Ferrera E, Sheehan N, Autmizguine J, Money D, Boucoiran I. Evaluation of Cabergoline for Lactation Suppression in Women Living with HIV. 7th HIV & Women International Workshop. Seattle (US), Feb 2017 and Annual Canadian Conference on HIV/AIDS Research, Montreal (Qc), May 2017.
  2. Boucoiran I, Mayer BT, Krantz E, Boppana S, Wald A, Corey L, Casper C, Schiffer JT, Gantt S. Recurrent maternal CMV infection following primary infection in infants. CMV Public Heath and Policy Conference. Austin (US), Sep 2016.
  3. Smiljkovic M, Renaud C, Leduc D, Boucoiran I, Lamarre V, Kakkar F. Quantitative PCR guided management of congenital CMV infection: A single center review. CMV Public Heath and Policy Conference. Austin (US), Sep 2016.
  4. Côté J, Rouleau G, Boucoiran I, Pichette N, de Pokomandy A. TAVIE Femme : Une intervention virtuelle au service des femmes vivant avec le VIH pour soutenir la prise des antirétroviraux. Colloque « Les femmes et le VIH : Recherche et pratiques d’intervention », 84th meeting of the “Association Francophone pour le Savoir”, Montréal (Qc), May 2016.
  5. Boucoiran I, Lee T, Tulloch K, Sauve L, Samson L, Brophy J, Boucher M and Money D for and members of the Canadian Pediatric HIV Surveillance Program (CPHSP). The use of antiretroviral agents during pregnancy in Canada and compliance with North-American guidelines. 6th HIV & Women International Workshop. Boston (US), Feb 2016.
  6. Desjardins M, Boucoiran I, Labbé AC, Paquet C, Laferrière C, Gosselin-Brisson A, Martel-Laferrière V. Pratiques québécoises en matière de dépistage des maladies évitables par la vaccination chez la femme enceinte. Journée de la recherche de microbiologie de l’Ude M, January 2015, Journées annuelles de formation de l'AMMIQ (JAFA), Quebec, May 2015
  7. Thériault K, Boucoiran I, Jarcevic R, Dal Soglio D, Wavrant S. Added value of placental examination in the investigation of stillbirth. 36st Annual Meeting of the Society for Maternal-Fetal Medicine, Atlanta (USA), Feb 2015.
  8. Boucoiran I, Kakkar F, Lee T, Sauve L, Singer J, Samson L, Money D and members of the Canadian Pediatric HIV Surveillance Program (CPHSP). Risk factors for Preterm Birth Among Women Living with HIV in Canada: Role of Antiretroviral Therapy Regimen Used in Pregnancy. Infectious Diseases Society for Obstetrics and Gynecology (IDSOG) Annual Meeting, Stowe, Vermont (US), Aug 2014.
  9. Picard A, Boucoiran I, Wavrant S, Dube J, Bujold E, Audibert F. Intra-amniotic sludge observed at cervical ultrasound and the risk of preterm delivery. 23rd World Congress on Ultrasound in Obstetrics and Gynecology, Sydney (Australia), Sept 2013.
  10. Boucoiran I, Van Schalkwyk J, Alimenti A, Maan E, Albert A, Wagner E, Chaworth-Muster T, Forbes J, Pick N, Money D, Oak Tree Clinic Research Group HIV Viral Rebound Near Delivery In Previously suppressed, Combined Antiretroviral Therapy Treated Pregnant Women. Infectious Diseases Society for Obstetrics and Gynecology (IDSOG) Annual meeting, Santa Ana Pueblo (US), Aug 2013.
  11. Boucoiran I, Van Schalkwyk J, A. Bahji, T. Chaworth-Musters, E. Maan, A. Alimenti, A. Albert, J. Forbes, N. Pick, D. Money. Time To HIV Viral Load Suppression With Combination Antiretroviral Therapy In Pregnancy: Time Of Initiation Counts. IDSOG Annual meeting, Santa Ana Pueblo (US), Aug 2013.
  12. Boucoiran I, Tulloch K, Pick P, Kakkar F, van Schalkwyk J, Money D, Boucher M. Third Trimester Raltegravir Initiation: The Impact On Maternal HIV Viral Load And Obstetrical Outcome. IDSOG Annual meeting, Santa Ana Pueblo (US), Aug 2013.
  13. Gaulin S, Boucoiran I, Audibert F, Rey E. Prévalence de diabète en présence de clarté nucale augmentée. Congrès Annuel de l’Association des Obstétriciens et Gynécologues du Québec, Jun 2013. 69th Annual clinical meeting of the Society of Obstetricians and Gynecologists of Canada, Calgary (Al), Jun 2013.
  14. Picard A, Boucoiran I, Dubé J, Wavrant S, Bujold E, Audibert F. Impact de la boue intra-amniotique (« sludge ») sur le risque d’accouchement premature. Congrès Annuel de L’Association des Obstétriciens et Gynécologues du Québec, Baie-St-Paul (Qc), Jun 2013.
  15. Martillotti G, Boucoiran I, Morin L, Fouron JC. Is the circulatory dynamics of fetuses with gastroschisis different from normal? 22st World Congress on Ultrasound in Obstetrics and Gynecology, Copenhagen (Denmark), Sept 2012.
  16. Maisonneuve E, Delvin E, Levy E, Ouellet A, Grenier E, Morin L, Dubé J, Boucoiran I, Bouity-Voubou M, Moutquin JM, Fouron JC, Klam S, Leduc L. Severity of foetal growth restriction from placental insufficiency is associated with a oxidative stress markers response in umbilical cord blood. 22st World Congress on Ultrasound in Obstetrics and Gynecology, Copenhagen (Denmark), Sept 2012.
  17. Thissier-Levy S, Boucoiran I, Wu Y, Wei Sq, Luo Zc, Nuyt Am, Julien P, Fraser W, Audibert F. Endostatine et risque de prééclampsie. Journée Francophone de Recherche en Obstétrique et Gynécologie, Paris (France), Dec 2011.
  18. Boucoiran I, Taillefer C, Wavrant S, Morin L, Dubé J, Hudon L, Audibert F. First trimester prediction of birth weight. 21st World Congress on Ultrasound in Obstetrics and Gynecology, Los Angeles (USA), Sep 2011.

Poster Presentations

  1. Côté J, Rouleau G, Boucoiran I, dePokomandy A, Brochet M-S, Morin C, Pichette N, Hot A, Monteith K . A web-based virtual nursing intervention to meet the specific needs of women living with HIV taking antiretroviral treatment. Annual Canadian Conference on HIV/AIDS Research, Montreal (Qc), May 2017
  2. F. Kakkar F, I. Boucoiran I, Valois S, Lamarre V, Renaud C, Soudeyns H, Lapointe N, Boucher M. The CMIS Cohort (1988-2015): Progress in the prevention of mother to child transmission in a resource-Rich Setting. Annual Canadian Conference on HIV/AIDS Research, Montreal (Qc), May 2017
  3. Minsart AF, McClymont E, Varin J, van Schalkwyk J, Boucher M, Money D, Boucoiran I. Causes of Preterm Delivery Among HIV-Positive Women in Canada and Association with Antiretroviral Exposure. Annual Canadian Conference on HIV/AIDS Research, Montreal (Qc), May 2017
  4. Placenta Progesterone Levels are Negatively Associated with Placenta Mitochondrial DNA Content among HIV+ and HIV- women in the CARMA-PREG cohort. Annual Canadian Conference on HIV/AIDS Research, Montreal (Qc), May 2017
  5. Minsart AF, Smiljkovic M, Christian R, Gagné MP, Lamarre V, Kakkar F, Boucher M, Boucoiran I. CMV-specific hyperimmunoglobulins in pregnancy: tolerance and pregnancy outcome. Canadian Perinatal Research Meeting, Montebello (Qc), Feb 2017.
  6. Renaud C, Lamarre V, Rypens F, Fallet-Bianco C, Kakkar F, Boucher M, Soudeyns H , Boucoiran I. Zika virus infection in pregnancy: a single centre experience. Canadian Perinatal Research Meeting, Montebello (Qc), Feb 2017.
  7. Smiljkovic M, Renaud C, Leduc D, Boucoiran I, Lamarre V, Kakkar F. Use of qPCR in Blood and CSF as a Predictor of Severity in Congenital CMV Infection. IDweek, New Orleans (US), Oct 2016.
  8. Boucoiran I, Boucher M, Varin J, Kakkar F, Money D. Causes of Preterm Birth Among HIV-Positive Women in Canada and Association with Antiretroviral Exposure. Infectious Diseases Society for Obstetrics and Gynecology (IDSOG) Annual Meeting, Annapolis (US), August 2016.
  9. Delangre E, Rabamaad L, Boucoiran I, Lamarre V, Kakkar F, Renaud C. Complexity of in-house verification of anti-cmv igg avidity assay in the context of low prevalence and rarity of gold standard sera. 32nd Clinical Virology Symposium, Daytona, FL, May 2016.
  10. Desjardins M, Boucoiran I, Labbé AC, Paquet C, Laferrière C, Gosselin-Brisson A, Martel-Laferrière V. Dépistage et prévention des malades évitables par la vaccination chez la femme enceinte), Congrès annuel de l'Association canadienne des sages-femmes, Montréal, Nov 2015.
  11. Desjardins M, Labbé AC, Boucoiran I, Paquet C, Laferrière C, Gosselin-Brisson A, Martel-Laferrière V. Influenza Vaccine in Pregnancy: Low Compliance Rate Among Healthcare Providers, Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego (US), Sept 2015.
  12. Desjardins M, Boucoiran I, Labbé AC, Paquet C, Laferrière C, Gosselin-Brisson A, Martel-Laferrière V. Impact of Vaccination History on Serology Testing in Pregnant Women, Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego (US), Sept 2015.
  13. Kakkar F, Boucoiran I, Lee T, Sauve L, Singer J, Samson L, Money D and members of the Canadian Pediatric HIV Surveillance Program (CPHSP). High Rates of Preterm Birth and Small for Gestational Age in a Cohort of HIV Infected Women in Canada: Role of Ritonavir Boosted Regimens? IDWeek, Philadelphia (US), Oct 2014.
  14. Vaujois L, Boucoiran I, Houde C, Fouron JC, Raboisson MJ. The absence of physiological shunts during the fetal period can help predict severe post-natal hypoxia in fetuses with transposition of the great arteries with intact ventricular septum. 6th World Congress of Paediatric Cardiology and Cardiac Surgery, Cape Town (South Africa), Feb 2013.
  15. Boucoiran I, Wavrant S, Rypens F. Prenatal diagnosis of hydromylia: a case report. 22st World Congress on Ultrasound in Obstetrics and Gynecology, Copenhagen (Denmark), Sept 2012.
  16. Martillotti G, Boucoiran I, Dubé E, Damphousse A, Grignon A, Moussa A, Bouchard S, Morin L. Predicting gastroschisis perinatal outcome from antenatal characteristics. 22st World Congress on Ultrasound in Obstetrics and Gynecology, Copenhagen (Denmark), Sept 2012.
  17. Clermont ME, Morin L, Boucoiran I, Dubé J, Codsi E, Audibert F, Wavrant S. Validity of first trimester 3D fetal anatomy assessment. 22st World Congress on Ultrasound in Obstetrics and Gynecology, Copenhagen (Denmark), Sept 2012.
  18. Boucoiran I, Delvin E, Rypens F, Rey E, Audibert F. Repeated measures of PlGF, PP13 and ADAM12 at first and second trimester for preeclampsia screening. 32st Annual Meeting of the Society for Maternal-Fetal Medicine, Dallas (USA), Feb 2012.
  19. Boucoiran I, S. Thissier-Levy S, Wu Y, Wei SQ, Luo ZC, Delvin E, Fraser W, Audibert F. Risk for preeclampsia and intrauterine growth restriction: effective value of PlGF, Sflt-1 and Inhibin A in singleton and multiple pregnancies. 32st Annual Meeting of the Society for Maternal-Fetal Medicine, Dallas (USA), Feb 2012.
  20. Thissier-Levy S, Boucoiran I, Wu Y, Wei SQ, Luo ZC, Nuyt AM, Fraser W, Audibert F. Endostatin: a new biomarker of preeclampsia? 32st Annual Meeting of the Society for Maternal-Fetal Medicine, Dallas (USA), Feb 2012.
  21. Wavrant S, Boucoiran I, Maisonneuve E, Audibert F, Rypens R. Prenatal diagnosis of schizencephaly: two cases. 21st World Congress on Ultrasound in Obstetrics and Gynecology, Los Angeles (USA), Sept 2011.
  22. Wavrant S, Boucoiran I, Tordjman L, Gauthier R, Bortoluzzi P, Rypens F, Morin L, Audibert F. Severe fetal head moulding without labor. 21st World Congress on Ultrasound in Obstetrics and Gynecology, Los Angeles (USA), Sept 2011.

Browse this profile on: